Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction
RecruitingNCT06544447Phase: PHASE1, PHASE2Started 2021-06-01
Summary
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 270 patients
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
China Beijing TongRen Hospital, Capital Medical University BBeijing, Beijing Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06544447